New Delhi’s pharmaceutical landscape is buzzing with optimism as India’s API market, worth $15-16 billion today, projects 5-7% CAGR through FY27 and FY28. CareEdge Ratings’ latest analysis points to favorable …
Tag:
Pharma Sector India
-
-
In the midst of trade negotiations between India and the United States, one sector stands out with unshakeable confidence: pharmaceuticals. India’s edge in cost-effective drug production has made it indispensable …